Skip to content
Open access

Osteosarcopenia Revisited: From Mechanisms to Management.

Aug 2026 · Journal of Bone and Mineral Research · 0 citations
Medicine

TL;DR

To manage and treat osteosarcopenia, a multimodal approach, such as exercise therapy, nutritional supplementation, and pharmacotherapies, is required, and emerging drugs that positively regulate bone and muscle mass are under development and are expected to contribute to individually optimized care.

Abstract

Sarcopenia and osteoporosis are characterized by insufficient mass and function of skeletal muscle and bone, and often co-occur in older persons, a condition called osteosarcopenia. Loss of bone and skeletal muscle mass and function is driven by multiple risk factors that activate the hallmarks of aging. Recent genome-wide association studies in humans and animal models suggest pivotal roles for mitochondria, the nucleus, and nutrient anabolism, which are closely associated with the hallmarks of aging, as well as for osteokines and myokines, in the development of osteosarcopenia. Osteosarcopenia is associated with a higher risk of adverse outcomes, such as falls, fractures, depression, and frailty, and consequently with mortality. Diagnosis of osteosarcopenia involves various imaging techniques to assess bone mineral density and skeletal muscle mass, as well as assessments of physical performance or muscle function. Moreover, a comprehensive evaluation of medical history, medications, and laboratory data is important for identifying potential contributing factors and assessing risk. To manage and treat osteosarcopenia, a multimodal approach, such as exercise therapy, nutritional supplementation, and pharmacotherapies, is required. Future prospects include technological innovations such as artificial intelligence and the identification of novel biomarkers based on multi-omics analyses, which will help enhance early detection of this condition. Emerging drugs that positively regulate bone and muscle mass are under development and are expected to contribute to individually optimized care for osteosarcopenia.

Read PDF

Similar papers

Review Open access Sep 2026

The Inter-relationship between Sarcopenia and Osteoporosis : Molecular Mechanisms and Therapeutic Interventions.

This narrative review synthesizes current evidence supporting osteosarcopenia as an integrated musculoskeletal syndrome, with a particular focus on biomechanical loading, biochemical crosstalk, and inflammatory signaling.

Jeonghyeon Seo, Sang Hoon Hwang, J. Yoon et al. · 0 citations
Open access Oct 2026

Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions

There was no statistically significant evidence that osteoporosis and sarcopenia co-occurred more often than expected under statistical independence, across several sarcopenia definitions, although estimates for confirmed sarcopenia were imprecise.

R. Matijevič, Milan Tošić, Filip Lažetić et al. · 0 citations
Review Sep 2026

[Sarcopenia in gastrointestinal oncology: Diagnostic criteria, clinical implications and management].

Sarcopenia is defined as a loss of muscle mass and strength. It represents a frequent and multifactorial complication in patients with gastrointestinal cancers, resulting from the combined effects of malnutrition, chronic inflammation, metabolic alterations, and reduced physical activity level. Its assessment relies on...

Géraldine M. Camilleri, Eléa Janvier, F. Pigneur et al. · 0 citations
Review 2026

Advances in Osteosarcopenia

Eleven typical literatures about osteosarcopenia published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on osteosarcopenia.

Enrico Buccheri, J. M. Nolla, M. Pourhassan · 0 citations
Open access Sep 2026

Osteosarcopenia as a Risk Factor for Atrial Fibrillation: A Multi-Cohort Study.

BACKGROUND Osteosarcopenia, characterized by concurrent reductions in skeletal muscle mass and bone mineral density, is an emerging geriatric syndrome. Although sarcopenia and osteoporosis have been individually linked to atrial fibrillation (AF), the association between osteosarcopenia and incident AF remains unclear....

Kyung-Yeon Lee, Tae-Min Rhee, Jungmin Choi et al. · 0 citations
Review Open access Sep 2026

Myosteatosis: an emerging biomarker of aging

Adipose tissue infiltration into skeletal muscle (i.e., myosteatosis) has emerged as an independent contributor to metabolic disorders and declines in skeletal muscle function with age. It remains unclear whether myosteatosis is a marker of aging or simply a consequence of disease or disuse. This review summarizes evid...

L. Roe, Joseph M. Zmuda, Iva Miljkovic · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.